Clinical trial
Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
NCT00818779
Study timeline
Study start (unknown)2008-01-01Date precision: month
Registry last updated2017-12-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Coronary Artery Diseaseunresolved
Type 2 Diabetes Mellitusunresolved
Interventions
AliskirenDRUG · verified · RxNorm: aliskiren
AmlodipineDRUG · verified · RxNorm: amlodipine
Sponsors & collaborators
Texas Tech University Health Sciences Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00818779 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.